AYAAN PARIKH

Ayaan Parikh is the founder of an undisclosed early-stage biotechnology startup developing artificial intelligence agents to identify and acquire pharmaceutical drug assets. He completed his academic training in computer science and bioengineering at Stanford University, operating at the intersection of computational technology and biological sciences. During his academic career, Parikh contributed extensively to scientific research, ultimately publishing four peer-reviewed papers focused specifically on molecular dynamics. Prior to his current artificial intelligence venture, he established his entrepreneurial background by founding three distinct healthtech companies that operated across the telemedicine, addiction recovery, and hydroponic system sectors. His professional experience also includes strategic advisory and investment analysis roles within biotechnology venture capital and healthcare consulting. Parikh currently focuses on leveraging his dual expertise in computer science and biology to automate and accelerate early-stage drug discovery and asset acquisition.